Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 49387

AbstractDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Reviews
Year : 2023 | Month : December | Volume : 17 | Issue : 12 | Page : JE09 - JE12 Full Version

Factors Causing Cardiovascular Diseases in Young Adults: A Narrative Review


Published: December 1, 2023 | DOI: https://doi.org/10.7860/JCDR/2023/65328.18851
Anushka Bandawar, Trupti Balwir, Ujwal Gajbe, Brijraj Singh, Yugeshwari Tiwade

1. Undergraduate Student, Datta Meghe Medical College, Nagpur, Datta Meghe Institute of Higher Education and Research (DU), Sawangi (Meghe), Wardha, Maharashtra, India. 2. Professor, Department of Anatomy, Datta Meghe Medical College, Nagpur, Datta Meghe Institute of Higher Education and Research (DU), Sawangi (Meghe), Wardha, Maharashtra, India. 3. Professor, Department of Anatomy, Datta Meghe Medical College, Nagpur, Datta Meghe Institute of Higher Education and Research (DU), Sawangi (Meghe), Wardha, Maharashtra, India. 4. Professor, Department of Anatomy, Datta Meghe Medical College, Nagpur, Datta Meghe Institute of Higher Education and Research (DU), Sawangi (Meghe), Wardha, Maharashtra, India. 5. Junior Research Fellow, Department of Pathology, Jawaharlal Nehru Medical College, Sawangi, Datta Meghe Institute of Higher Education and Research (DU), Sawangi (Meghe), Wardha, Maharashtra, India.

Correspondence Address :
Dr. Ujwal Gajbe,
Professor, Department of Anatomy, Datta Meghe Medical College, Nagpur, Datta Meghe Institute of Higher Education and Research (DU), Sawangi (Meghe), Wardha-442004, Maharashtra, India.
E-mail: drujwal1970@gmail.com

Abstract

Cardiovascular Diseases (CVD) are a major public health problem worldwide. They continue to be one of the leading causes of death worldwide, and it is alarming that these diseases are becoming more common in people of the young age group. Although various risk factors have been proposed, smoking, dyslipidemia, and hypertension are prominent emerging risk factors in the young. The primary pathogenic mechanism for most cardiovascular disorders, such as coronary artery disease, peripheral vascular disease, heart failure, and Myocardial Infarction (MI), is atherosclerosis. Plaque rupture is the most common cause of MI, although distinctive symptoms such as plaque erosion, coronary microvascular dysfunction, spontaneous coronary artery dissection, and drug-related coronary spasm are more common in this age range. Various lifestyle factors, including, but not limited to, physical inactivity, tobacco use, alcohol consumption, poor eating habits, and drug abuse, contribute to the development of comorbid conditions such as hypertension, hypercholesterolemia, obesity, and diabetes, increasing the likelihood of having heart disease. To mitigate the societal impact of CVD and promote a healthier future for the next generation, proactive measures, such as regular physical activity and a balanced diet, are essential. This will be addressed in terms of lifestyle, environmental, physiological, pathological, and psychological aspects.

Keywords

Atherosclerosis, Myocardial infarction, Obesity, Sedentary lifestyle

The CVD are the leading cause of global mortality. While the incidence has declined in older populations, it is on the rise among younger individuals, especially in cases of MI (1). In India, Coronary Artery Disease (CAD) affects people at a younger age, with over 50% of CVD deaths occurring in individuals under the age of 50 years (2). (Table/Fig 1) provides an overview of the factors associated with cardiac diseases.

Previous research suggests that external factors such as stress, obesity, sedentary lifestyle, lack of exercise, alcohol abuse, drug abuse, and smoking, as well as hormonal imbalances, can trigger MI (3). Additionally, underlying or inherited diseases like familial hyperlipidaemia, type 2 diabetes, and hypercholesterolemia impact the cardiovascular system, leading to cardiac diseases (4). Sex differences also play a role, as heavy physical activities and dietary habits are more frequently associated with MI in men, while emotions and stress are common triggers among females (5). CVD primarily stems from atherosclerosis, a pathological process underlying the development of conditions like peripheral vascular disease and coronary artery disease, ultimately leading to a MI (6).

The present article provides an overview of various factors contributing to the increased risk of heart attacks in young adults, highlighting the complex interplay of lifestyle, environmental, physiological, pathological, and psychological factors underlying this trend.

Discussion

a. Obesity and its effects on the cardiovascular system: Obesity is a medical disorder characterised by the accumulation of excess body fat, often caused by a high calorie intake and a low physical activity. The factors contributing to obesity are outlined in (Table/Fig 2) (7).

Obesity is a significant risk factor for CVD (8). In urban areas, the Body Mass Index (BMI) tends to be higher (24-25 kg/m2) compared to rural areas (20 kg/m2) (9). Adult BMIs above 21 kg/m2 are associated with the development of Type 2 Diabetes Mellitus (T2DM), ischaemic heart disease, stroke, and hypertension, primarily due to accelerated atherosclerosis and long-term obesity (9). Over time, obesity has been shown to negatively affect the anatomy of the heart, as well as the systolic and diastolic functions of the left ventricle, particularly diastolic activities (10).

b. P Physical inactivity and its detrimental effects on the cardiovascular system: Physical inactivity refers to a lack or complete absence of exercise and is a significant contributor to decreased life expectancy. Various factors contribute to increased physical inactivity, including individual, societal, and cultural reasons. Modern lifestyle, urbanisation, increased screen time, and lack of motivation or interest in exercise are some of the main factors. Physical inactivity, coupled with a high-calorie diet, especially among young people, contributes to the rise in obesity. It is associated with metabolic disorders such as impaired glucose metabolism, insulin resistance, decreased cardiorespiratory fitness, increased blood pressure, and higher BMI. Additionally, physical inactivity leads to reduced blood flow, which damages vascular function and is associated with the development of CVD (11).

c. Stress and its effects on the cardiovascular system: Stress is a normal state of worry or mental tension caused by various situations. There are different types of stress, including acute and chronic stress, both of which can have serious cardiovascular effects (12). Young adults experience stress due to various reasons, such as family pressure, academic problems, financial burdens, self-doubt, and peer pressure (13). These factors contribute to stress, increasing the risk of CVD by activating the autonomic nervous system and impacting cardiovascular system functioning. Chronic stress exposure plays a significant role in the development of atherosclerosis and other related chronic health problems. Short-term stressors activate the sympathetic nervous system, resulting in negative effects such as hypertension, increased blood viscosity, and endothelial cell dysfunction (12). Stress causes the activation of the sympathetic nervous system in individuals, leading to physiological responses such as elevated heart rate, arterial vasodilation, vasoconstriction, and increased cardiac muscle contractility due to the stimulating effect of the sympathetic nervous system on the cardiovascular system (14). It is important to note that these responses are normal and adaptive mechanisms that help respond to stressors, but prolonged activation of the sympathetic nervous system leads to negative health outcomes. Occasionally, stress can also activate the parasympathetic nervous system, resulting in decreased heart rate, reduced force of contraction, hypotension, reduced impulse, and peripheral vasodilation, which impede proper cardiovascular system functioning (15). Initially, the effect of stress is usually observed on heart rate (16). Psychological distress increases the risk factors associated with CVD because individuals experiencing stress are more likely to engage in unhealthy behaviours like smoking, alcohol abuse, drug abuse, and overeating (17).

d. Unhealthy diet and its effects on the cardiovascular system: An unhealthy or inadequate diet is a significant risk factor for CVD (18). Consuming a diet high in processed foods, added sugar, unhealthy fats, and low in fruits, vegetables, fibres, grains, and nuts, combined with a lack of exercise, obesity, alcohol abuse, and smoking, increases the risk of heart disease (18). Nutrients like vitamins, minerals, Polyunsaturated Fatty Acids (PUFA), and fibres have beneficial effects on the cardiovascular system by reducing inflammation, blood pressure, Low Density Lipoprotein (LDL) levels (bad cholesterol), maintaining body weight, and lowering the risk of thrombosis and myocardial infarction (19). Consumption of fruits and vegetables helps protect against reactive oxygen species, offering a potential mechanism for preventing CVD (20). Nuts are rich in tocopherols, phytosterols, phenolic chemicals, fibre, minerals, and high-quality vegetable protein with a healthy fatty acid composition that is high in unsaturated fats and low in saturated fats. They help lower cholesterol, reduce body fat mass and weight, and when included in calorie-restricted diets, aid weight loss and improve insulin sensitivity in obese 10individuals (21),(22). Consumption of nitrates and their by-products has been associated with endothelial dysfunction, insulin resistance, and atherosclerosis. Additionally, dietary sodium from processed foods can increase blood pressure and peripheral vascular resistance while diminishing arterial compliance (23). Canned fruit, compared to fresh fruit, may contain additional sugars and Bisphenol A, and the acidity of canned food can dissolve lead solder from food cans, which is a cause for concern (24). Given the substantial increase in the consumption of unhealthy processed and junk food, a proper diet is crucial in reducing the risk of CVD.

e. Cholesterol and the cardiovascular system: Cholesterol and lipid levels directly impact the cardiovascular system, as even modest increases in cholesterol or lipid levels are associated with a higher risk of CVD (25). Lipids and lipoproteins play a role in regulating the inflammatory process and the function of vascular and cardiac cells, thereby influencing the health of blood vessels and the heart. They also contribute to atherosclerosis, which is the underlying cause of CVD (26). LDL and other apo-B-containing lipoproteins transport cholesterol from the liver to tissues, significantly increasing the risk of atherosclerosis. On the contrary, High-Density Lipoprotein (HDL) is inversely correlated with CVD, as it transports cholesterol from tissues back to the liver, making it beneficial and referred to as “good” cholesterol (27).

Hyperlipidaemia: It is a condition characterised by higher-than-normal levels of lipids or lipoproteins in the blood. It manifests as an increase in LDL levels, triglyceride levels, total cholesterol levels, accompanied by a decrease in HDL levels (4). Hyperlipidaemia can be inherited (familial hyperlipidaemia) or acquired. Due to the increased likelihood of plaque formation in blood vessels due to cholesterol and triglyceride deposition, individuals with hyperlipidaemia are at an increased risk of developing CVD.

Hypercholesterolemia: It is a condition characterised by high levels of LDL, which increases the risk of CVD. It can be inherited (familial hypercholesterolemia) or acquired. Lifetime exposure to high levels of LDL caused by familial hypercholesterolemia increases the chance of developing atherosclerotic plaque and early CVD (28).

f. Hormones and their effects on the cardiovascular system: Many hormones directly influence organs and tissues, including the heart and cardiovascular system, through specific receptors in the heart or artery wall. Some hormones also function indirectly by stimulating other neuroendocrine processes (29). Hormones such as urotensin II, endothelin, angiotensin II, catecholamines, aldosterone, antidiuretic hormone, glucocorticosteroids, thyroid hormones, Growth Hormone (GH), and leptin can cause an increase in blood pressure. On the other hand, natriuretic peptides, Calcitonin Gene-Related Peptides (CGRP), angiotensin 1-7, substance P, neurokinin A, ghrelin, Parathyroid Hormone-Related Protein (PTHrP), oxytocin, and sex hormones can lower blood pressure (29). Excess levels of hormones like leptin, PTHrP, endothelin, thyroid hormones, glucocorticoids, catecholamines, and endothelins can increase heart rate, while hormones like natriuretic peptides, substance P, neurokinin A, oxytocin, and angiotensins 1-7 can decrease heart rate (29).

Oestrogen: Oestrogen plays a role in regulating the cardiovascular system. It improves lipid profiles by significantly increasing HDL levels and lowering LDL levels, which is beneficial for the heart and blood vessels. Oestrogen also promotes vasodilation, angiogenesis, and reduces oxidative stress and fibrosis, exerting its cardioprotective function. Postmenopausal women, who have lower oestrogen levels, have a higher prevalence of CVD (30).

Testosterone: Testosterone affects the cardiovascular system in various ways. Male testosterone levels start to decline around the age of 40, which is associated with a higher risk of CVD in men (31).

Studies suggest that raising serum testosterone levels can reduce the risk of myocardial ischaemia and cardiac mortality in men. Testosterone increases coronary blood flow, coronary vasomotion, and exercise capacity in heart failure (31),(32),(33). Testosterone binds to cytoplasmic Androgen Receptors (AR), which are chaperoned by heat shock proteins. The testosterone-AR complex migrates to the nucleus, where it dimerises with another complex, binds to coactivator proteins, and transactivates a family of genes with androgen response elements, altering the behaviour of myocardial and vascular cells (31).

Thyroid hormones: Changes in thyroid hormone levels can increase the risk of MI and other cardiac diseases (34). Thyroid dysfunction can cause cardiovascular abnormalities (35). Thyroid hormones have both cardiac chronotropic (effect on heart rate) and inotropic (effect on force of contraction) effects. In the normal range, these effects are beneficial, but they can also have negative effects on the cardiovascular system (34). Thyroid hormone reduces peripheral vascular resistance and increases cardiac output by lowering diastolic blood pressure through low systemic vascular resistance. Thyroid hormone also plays a role in controlling HDL and LDL levels. Individuals with hypothyroidism have elevated levels of LDL, Very Low Density Lipoprotein (VLDL), HDL, apolipoprotein B-71 (Apo B71), and lipoprotein(a), which contribute to the development of atherosclerosis (34). Other effects of thyroid hormone include cardiac hypertrophy, increased cardiac output, greater cardiac effort, and increased cardiac contractility. Thyroid hormone has direct effects on cardiac myocytes, as well as indirect effects on haemodynamic parameters and peripheral oxygen consumption (36).

Growth Hormone (GH): GH is primarily responsible for regulating somatic development, but it also helps maintain muscle mass and strength, regulate body composition, and manage food metabolism (37). There is evidence linking GH and/or its regional effector Insulin-Like Growth Factor I (IGF-I) to the processes involved in controlling heart development and hypertrophy (38). GH directly influences heart composition and operations, and changes in GH levels have been shown to impact vascular stiffness and peripheral systemic resistance (39). Patients with Growth Hormone Deficiency (GHD) have thinner left ventricular posterior walls, lower left ventricular mass indices, impaired cardiac contractility, and a higher likelihood of developing hypertension, which can lead to heart enlargement and congestive heart failure (40). Individuals with GHD also have low HDL levels and high LDL and total cholesterol levels (41). Conversely, patients with early-stage acromegaly, who have chronically high GH levels, are more likely to experience an increase in cardiac index and cardiac output, a decrease in vascular resistance, and elevated blood glucose levels (42).

g. Smoking and the cardiovascular system: Smoking is one of the main risk factors for CVD and a leading preventable cause of cardiac mortality (43). Since smoking has been more popularised in young generation, the prevalence of cardiovascular problems in this age range has increased (9),(44). The composition of cigarettes includes harmful substances such as nicotine, hydrogen cyanide, formaldehyde, lead, arsenic, ammonia, radioactive elements, and benzene. Nicotine has adrenergic effects on the cardiovascular system, resulting in increased heart rate, reduced insulin sensitivity, increased inotropic status, and endothelial dysfunction (45). Smoking can compromise oxygen delivery to tissues due to increased carboxyhaemoglobin levels, increasing the risk of tissue necrosis (46).

g. Alcohol and the cardiovascular system: Alcohol intake is associated with a higher risk of developing CVDs, such as coronary artery disease, leading to heart failure and cardiac mortality (47). Moderate alcohol consumption can benefit the cardiovascular system by increasing HDL, reducing LDL oxidation, improving insulin sensitivity, having antioxidant effects, and reducing fibrinogen (47). However, alcohol abuse is associated with the development of cardiac arrhythmias, atrial fibrillation, toxic effects on cardiac monocytes, and an increased risk of stroke (48). Alcohol addiction has been observed in young people, further increasing the risk of cardiac death.

i. D Drug abuse and the cardiovascular system: Drug abuse has increased in recent years among young people, whether as a result of peer pressure, a desire to try new things or as a means of escaping reality and pressures. As a result, the risk of CVD has increased (49),(50). Drug abuse is the most common preventable cause of CVD. Cannabis, opioids (such as heroin and morphine), cocaine, charas, ganja, etc., are the most exploited drugs in India (51).

Cannabinoids: The activation of Cannabinoid Receptor type 1 (CB1R) in humans promotes endothelial dysfunction, which is a crucial factor in the development of atherosclerosis and cardiac diseases (52). CB1R activation triggers pathways that prevent normal vasodilation in endothelial cells (53).

Cocaine: Cocaine has a well known ability to cause vasoconstriction of the coronary arteries. Coronary arteries tend to have more spasms in cocaine users, furthermore, cocaine reduces blood flow, which reduces oxygen supply and increases oxygen demand in the myocardium (54). Cocaine is an adrenergic agonist because it prevents norepinephrine from being reabsorbed and releases epinephrine from the adrenal glands, it also inhibits sodium channels, reducing the resting membrane potential and the amplitude of the action potential while increasing the duration of the action potential (55).

Conclusion

A sedentary lifestyle, unhealthy diets, stress, smoking, alcohol and drug abuse, as well as inherited or acquired disorders like hyperlipidaemia, are the main risk factors contributing to the alarming rise in CVDs among young people. To prevent this increasing trend, it is recommended to maintain a balanced diet and engage in regular exercise. It is important to avoid smoking, alcohol, and drug abuse. Additionally, maintaining a healthy weight and managing stress are crucial. Early detection and control of risk factors such as hypertension, high cholesterol, hormone deficiencies, and diabetes are critical in preventing the progression of CVD.

References

1.
Gulati R, Behfar A, Narula J, Kanwar A, Lerman A, Cooper L, et al. Acute myocardial infarction in young individuals. Mayo Clin Proc. 2020;95(1):136-56. [crossref][PubMed]
2.
Dalal J, Hiremath MS, Das MK, Desai DM, Chopra VK, Biswas AD. Vascular disease in young Indians (20-40 years): Role of ischemic heart disease. J Clin Diagn Res JCDR. 2016;10(9):OE08-OE12. [crossref][PubMed]
3.
Sood A, Singh A, Gadkari C. Myocardial infarction in young individuals: A review article. Cureus. 2023;15(4):e37102.
4.
Alloubani A, Nimer R, Samara R. Relationship between hyperlipidemia, cardiovascular disease and stroke: A systematic review. Curr Cardiol Rev. 2021;17(6):e051121189015. [crossref][PubMed]
5.
Olsson A, Mohammad MA, Rylance R, Platonov PG, Sparv D, Erlinge D. Sex differences in potential triggers of myocardial infarction. Eur Heart J Open. 2023;3(2):oead011. [crossref][PubMed]
6.
Flora GD, Nayak MK. A brief review of cardiovascular diseases, associated risk factors and current treatment regimes. Curr Pharm Des. 2019;25(38):4063-84. [crossref][PubMed]
7.
Barua S, Saikia N. Perception, risk factors, and health behaviours in adult obesity in Kolkata, India: A mixed methods approach. BMC Public Health. 2022;22:2376. [crossref][PubMed]
8.
Ahirwar R, Mondal PR. Prevalence of obesity in India: A systematic review. Diabetes Metab Syndr. 2019;13(1):318-21. [crossref][PubMed]
9.
Sreeniwas Kumar A, Sinha N. Cardiovascular disease in India: A 360 degree overview. Med J Armed Forces India. 2020;76(1):01-03. [crossref][PubMed]
10.
Ortega-Loubon C, Fernández-Molina M, Singh G, Correa R. Obesity and its cardiovascular effects. Diabetes Metab Res Rev. 2019;35(4):e3135. [crossref][PubMed]
11.
Melo EAS de, Ferreira LE de S, Cavalcanti RJF, Botelho Filho CA de L, Lopes MR, Barbosa RH de A. Nuances between sedentary behavior and physical inactivity: Cardiometabolic effects and cardiovascular risk. Rev Assoc Medica Bras 1992. 2021;67(2):335-43. [crossref][PubMed]
12.
Kario K, McEwen BS, Pickering TG. Disasters and the heart: A review of the effects of earthquake-induced stress on cardiovascular disease. Hypertens Res Off J Jpn Soc Hypertens. 2003;26(5):355-67. [crossref][PubMed]
13.
Mofatteh M. Risk factors associated with stress, anxiety, and depression among university undergraduate students. AIMS Public Health. 2020;8(1):36-65.[crossref][PubMed]
14.
Tiwari R, Kumar R, Malik S, Raj T, Kumar P. Analysis of heart rate variability and implication of different factors on heart rate variability. Curr Cardiol Rev. 2021;17(5):e160721189770. [crossref][PubMed]
15.
Cohen H, Benjamin J, Geva AB, Matar MA, Kaplan Z, Kotler M. Autonomic dysregulation in panic disorder and in post-traumatic stress disorder: Application of power spectrum analysis of heart rate variability at rest and in response to recollection of trauma or panic attacks. Psychiatry Res. 2000;96(1):01-13. [crossref][PubMed]
16.
Vrijkotte TG, van Doornen LJ, de Geus EJ. Effects of work stress on ambulatory blood pressure, heart rate, and heart rate variability. Hypertens Dallas Tex 1979. 2000;35(4):880-86. [crossref][PubMed]
17.
Yaribeygi H, Panahi Y, Sahraei H, Johnston TP, Sahebkar A. The impact of stress on body function: A review. EXCLI J. 2017;16:1057-72.
18.
Chareonrungrueangchai K, Wongkawinwoot K, Anothaisintawee T, Reutrakul S. Dietary factors and risks of cardiovascular diseases: An umbrella review. Nutrients. 2020;12(4):1088. [crossref][PubMed]
19.
Casas R, Castro-Barquero S, Estruch R, Sacanella E. Nutrition and cardiovascular health. Int J Mol Sci. 2018;19(12):3988. [crossref][PubMed]
20.
Alissa EM, Ferns GA. Dietary fruits and vegetables and cardiovascular diseases risk. Crit Rev Food Sci Nutr. 2017;57(9):1950-62.
21.
Ros E. Health benefits of nut consumption. Nutrients. 2010;2(7):652-82. [crossref][PubMed]
22.
Rajaram S, Sabaté J. Nuts, body weight and insulin resistance. Br J Nutr. 2006;96(Suppl 2):S79-86. [crossref][PubMed]
23.
Kwok CS, Gulati M, Michos ED, Potts J, Wu P, Watson L, et al. Dietary components and risk of cardiovascular disease and all-cause mortality: A review of evidence from meta-analyses. Eur J Prev Cardiol. 2019;26(13):1415-29. [crossref][PubMed]
24.
Aasheim ET, Sharp SJ, Appleby PN, Shipley MJ, Lentjes MAH, Khaw KT, et al. Tinned fruit consumption and mortality in three prospective cohorts. PloS One. 2015;10(2):e0117796. [crossref][PubMed]
25.
Kim MK, Han K, Kim HS, Yoon KH, Lee SH. Lipid cutoffs for increased cardiovascular disease risk in non-diabetic young people. Eur J Prev Cardiol. 2022;29(14):1866-77. [crossref][PubMed]
26.
Soppert J, Lehrke M, Marx N, Jankowski J, Noels H. Lipoproteins and lipids in cardiovascular disease: From mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev. 2020;159:04-33. [crossref][PubMed]
27.
Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459-72. [crossref][PubMed]
28.
Benito-Vicente A, Uribe KB, Jebari S, Galicia-Garcia U, Ostolaza H, Martin C. Familial hypercholesterolemia: The most frequent cholesterol metabolism disorder caused disease. Int J Mol Sci. 2018;19(11):3426. [crossref][PubMed]
29.
Lacka K, Czyzyk A. Hormones and the cardiovascular system. Endokrynol Pol. 2008;59(5):420-32.
30.
Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017;8(1):33. [crossref][PubMed]
31.
Goodale T, Sadhu A, Petak S, Robbins R. Testosterone and the heart. Methodist DeBakey Cardiovasc J. 2017;13(2):68-72. [crossref][PubMed]
32.
Morgentaler A. Testosterone deficiency and cardiovascular mortality. Asian J Androl. 2015;17(1):26-31. [crossref][PubMed]
33.
Webb MC, Collins P. Role of testosterone in the treatment of cardiovascular disease. Eur Cardiol Rev. 2017;12(2):83-87. [crossref][PubMed]
34.
Jabbar A, Pingitore A, Pearce SHS, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14(1):39-55. [crossref][PubMed]
35.
Vargas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH. Effects of thyroid hormones on the heart. Clin E Investig En Arterioscler Publicacion Of Soc Espanola Arterioscler. 2014;26(6):296-309. [crossref][PubMed]
36.
Mohr-Kahaly S, Kahaly G, Meyer J. Cardiovascular effects of thyroid hormones. Z Kardiol. 1996;85(Suppl 6):219-31.
37.
Saccà L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr Rev. 1994;15(5):555-73. [crossref][PubMed]
38.
Hanson MC, Fath KA, Alexander RW, Delafontaine P. Induction of cardiac insulin- like growth factor I gene expression in pressure overload hypertrophy. Am J Med Sci. 1993;306(2):69-74. [crossref][PubMed]
39.
Smith JC, Evans LM, Wilkinson I, Goodfellow J, Cockcroft JR, Scanlon MF, et al. Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: A randomized, double-blind, placebo-controlled study. Clin Endocrinol (Oxf). 2002;56(4):493-501. [crossref][PubMed]
40.
Isgaard J, Arcopinto M, Karason K, Cittadini A. GH and the cardiovascular system: An update on a topic at heart. Endocrine. 2015;48(1):25-35. [crossref][PubMed]
41.
Isgaard J. Cardiovascular disease and risk factors: The role of growth hormone. Horm Res. 2004;62(Suppl 4):31-38. [crossref][PubMed]
42.
Chanson P, Megnien JL, del Pino M, Coirault C, Merli I, Houdouin L, et al. Decreased regional blood flow in patients with acromegaly. Clin Endocrinol (Oxf). 1998;49(6):725-31. [crossref][PubMed]
43.
Kondo T, Nakano Y, Adachi S, Murohara T. Effects of tobacco smoking on cardiovascular disease. Circ J Off J Jpn Circ Soc. 2019;83(10):1980-85. [crossref][PubMed]
44.
Rai B, Bramhankar M. Tobacco use among Indian states: Key findings from the latest demographic health survey 2019-2020. Tob Prev Cessat. 2021;7:19. [crossref][PubMed]
45.
Gallucci G, Tartarone A, Lerose R, Lalinga VA, Capobianco AM. Cardiovascular risk of smoking and benefits of smoking cessation. J Thorac Dis. 2020;12(7):3866-76. [crossref][PubMed]
46.
Schimmel J, George N, Schwarz J, Yousif S, Suner S, Hack JB. Carboxyhemoglobin levels induced by cigarette smoking outdoors in smokers. J Med Toxicol. 2018;14(1):68-73. [crossref][PubMed]
47.
Goel S, Sharma A, Garg A. Effect of alcohol consumption on cardiovascular health. Curr Cardiol Rep. 2018;20(4):19. [crossref][PubMed]
48.
Day E, Rudd JHF. Alcohol use disorders and the heart. Addict Abingdon Engl. 2019;114(9):1670-78. [crossref][PubMed]
49.
Keyzers A, Lee SK, Dworkin J. Peer pressure and substance use in emerging adulthood: A latent profile analysis. Subst Use Misuse. 2020;55(10):1716-23. [crossref][PubMed]
50.
Goyal AK, Nimonkar R, Chopra V, Singh PMP. Drug abuse in North Kashmir- An experience from a drug de-addiction center. Ind Psychiatry J. 2022;31(2):331-35. [crossref][PubMed]
52.
Kumar S. India has widespread drug problem, report says. BMJ. 2004;329(7456):14. [crossref][PubMed]
52.
Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473(7347):317-25. [crossref][PubMed]
53.
Ghosh M, Naderi S. Cannabis and cardiovascular disease. Curr Atheroscler Rep. 2019;21(6):21. [crossref][PubMed]
54.
Flores ED, Lange RA, Cigarroa RG, Hillis LD. Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: Enhanced vasoconstriction at sites of significant stenoses. J Am Coll Cardiol. 1990;16(1):74-79. [crossref][PubMed]
55.
Karch SB. Cardiac arrest in cocaine users. Am J Emerg Med. 1996;14(1):79-81. [crossref][PubMed]

DOI and Others

DOI: 10.7860/JCDR/2023/65328.18851

Date of Submission: May 09, 2023
Date of Peer Review: Jul 12, 2023
Date of Acceptance: Sep 22, 2023
Date of Publishing: Dec 01, 2023

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? No
• For any images presented appropriate consent has been obtained from the subjects. No

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: May 12, 2023
• Manual Googling: Aug 18, 2023
• iThenticate Software: Sep 19, 2023 (16%)

ETYMOLOGY: Author Origin

EMENDATIONS: 6

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com